Medline Inc. (MDLN)
Nasdaq: MDLN · Surgical & Medical Instruments & Apparatus · Northfield, IL · filing with the SEC since 2024
Income statement, as filed
In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
| Report filed | Feb 25, 2026 | · | · |
| Revenue | 28,432 | 25,507 | 23,231 |
| Cost of revenue | 20,914 | 18,531 | 17,346 |
| Gross profit | 7,518 | 6,976 | 5,885 |
| Research and development | 80 | 67 | 60 |
| Selling, general and administrative | 4,524 | 4,108 | 3,867 |
| Total operating expenses | 5,306 | 4,830 | 4,635 |
| Operating income | 2,212 | 2,146 | 1,250 |
| Interest expense | 945 | 1,144 | 1,213 |
| Interest and investment income | 133 | 280 | 237 |
| Interest income (expense), net | -812 | -864 | -976 |
| Other income (expense), net | -64 | -43 | 1 |
| Total non-operating income (expense) | -964 | -900 | -986 |
| Income before income taxes | 1,248 | 1,246 | 264 |
| Income tax expense | 91 | 46 | 30 |
| Net income including non-controlling interests | · | 1,163 | 234 |
| Net income to non-controlling interests | -2 | · | · |
| Net income | 1,159 | · | · |
| Earnings per share, basic | -0.01 | · | · |
| Earnings per share, diluted | -0.01 | · | · |
| Weighted average shares, basic | 810,000,000 | · | · |
| Weighted average shares, diluted | 810,000,000 | · | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseNonoperatingInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding